{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:50:34Z","timestamp":1761155434774,"version":"build-2065373602"},"reference-count":53,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.bcmd.2010.09.001","type":"journal-article","created":{"date-parts":[[2010,11,8]],"date-time":"2010-11-08T04:05:41Z","timestamp":1289189141000},"page":"60-65","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Hip arthroplasty in patients with Gaucher disease"],"prefix":"10.1016","volume":"46","author":[{"given":"Ehud","family":"Lebel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Ioscovich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Menachem","family":"Itzchaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ari","family":"Zimran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Elstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2010.09.001_bb0005","series-title":"The Metabolic and Molecular Basis of Inherited Disease","first-page":"3635","article-title":"Gaucher disease","author":"Beutler","year":"2001"},{"key":"10.1016\/j.bcmd.2010.09.001_bb0010","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/humu.20676","article-title":"Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA)","volume":"29","author":"Hruska","year":"2008","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.bcmd.2010.09.001_bb0015","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1136\/jmg.2004.028019","article-title":"Divergent phenotypes in Gaucher disease implicate the role of modifiers","volume":"42","author":"Goker-Alpan","year":"2005","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.bcmd.2010.09.001_bb0020","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0140-6736(01)05490-3","article-title":"Eponym series: Gaucher's disease","volume":"358","author":"Elstein","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.bcmd.2010.09.001_bb0025","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/icb.2009.42","article-title":"Glucocerebroside: an evolutionary advantage for patients with Gaucher disease and a new immunomodulatory agent","volume":"87","author":"Ilan","year":"2009","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.bcmd.2010.09.001_bb0030","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1089\/gte.1998.2.297","article-title":"Asymptomatic Gaucher disease implications for large-scale screening","volume":"2","author":"Azuri","year":"1998","journal-title":"Genet. Test."},{"key":"10.1016\/j.bcmd.2010.09.001_bb0035","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s10545-008-0868-z","article-title":"Phenotypic heterogeneity of N370S homozygotes with type I Gaucher disease: an analysis of 798 patients from the ICGG Gaucher Registry","volume":"31","author":"Fairley","year":"2008","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bcmd.2010.09.001_bb0040","first-page":"565","article-title":"Adult-type Gaucher disease in children: genetics, clinical features and enzyme replacement therapy","volume":"86","author":"Zevin","year":"1993","journal-title":"Q. J. Med."},{"key":"10.1016\/j.bcmd.2010.09.001_bb0045","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/00005792-198509000-00003","article-title":"Skeletal complications of Gaucher's disease","volume":"64","author":"Stowens","year":"1985","journal-title":"Medicine"},{"key":"10.1016\/j.bcmd.2010.09.001_bb0050","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.berh.2008.09.005","article-title":"Musculoskeletal complications encountered in the lysosomal storage disorders","volume":"22","author":"Pastores","year":"2008","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"10.1016\/j.bcmd.2010.09.001_bb0055","doi-asserted-by":"crossref","first-page":"943","DOI":"10.2214\/ajr.147.5.943","article-title":"Gaucher's disease type 1: assessment of bone involvement by CT and scintigraphy","volume":"147","author":"Hermann","year":"1986","journal-title":"Am. J. Roentgenol."},{"key":"10.1016\/j.bcmd.2010.09.001_bb0060","doi-asserted-by":"crossref","first-page":"961","DOI":"10.2214\/ajr.179.4.1790961","article-title":"Quantification of skeletal involvement in adults with type I Gaucher's disease: fat fraction measured by Dixon quantitative chemical shift imaging as a valid parameter","volume":"179","author":"Maas","year":"2002","journal-title":"Am. J. Roentgenol."},{"key":"10.1016\/j.bcmd.2010.09.001_bb0065","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/(SICI)1096-8628(19990604)84:4<334::AID-AJMG5>3.0.CO;2-P","article-title":"Type 1 Gaucher disease presenting with extensive mandibular lytic lesions: identification and expression of a novel acid beta-glucosidase mutation","volume":"84","author":"Wasserstein","year":"1999","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.bcmd.2010.09.001_bb0070","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1006\/bcmd.2001.0479","article-title":"Biochemical markers of bone turnover as tools in the evaluation of skeletal involvement in patients with type 1 Gaucher disease","volume":"28","author":"Drugan","year":"2002","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bcmd.2010.09.001_bb0075","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s10067-010-1464-9","article-title":"Effect of vitamin D receptor (VDR) genotypes on the risk for osteoporosis in type 1 Gaucher disease","volume":"29","author":"Greenwood","year":"2010","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.bcmd.2010.09.001_bb0080","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1080\/00016470410004003","article-title":"Orthopedic considerations in Gaucher disease since the advent of enzyme replacement therapy","volume":"75","author":"Itzchaki","year":"2004","journal-title":"Acta Orthop. Scand."},{"key":"10.1016\/j.bcmd.2010.09.001_bb0085","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJM199105233242104","article-title":"Replacement therapy for inherited enzyme deficiency\u2013macrophage-targeted glucocerebrosidase for Gaucher's disease","volume":"324","author":"Barton","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcmd.2010.09.001_bb0090","doi-asserted-by":"crossref","first-page":"33","DOI":"10.7326\/0003-4819-122-1-199501010-00005","article-title":"Enzyme therapy in Gaucher disease type 1: comparative efficacy of mannose-terminated glucocerebrosidase from natural and recombinant sources","volume":"122","author":"Grabowski","year":"1995","journal-title":"Ann. Int. Med."},{"key":"10.1016\/j.bcmd.2010.09.001_bb0095","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/S0140-6736(95)91038-7","article-title":"Replacement therapy with imiglucerase for type 1 Gaucher's disease","volume":"345","author":"Zimran","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.bcmd.2010.09.001_bb0100","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1542\/peds.96.4.629","article-title":"Enzyme replacement therapy for Gaucher disease: skeletal responses to macrophage-targeted glucocerebrosidase","volume":"96","author":"Rosenthal","year":"1995","journal-title":"Pediatrics"},{"issue":"Suppl 1","key":"10.1016\/j.bcmd.2010.09.001_bb0105","doi-asserted-by":"crossref","first-page":"A25","DOI":"10.1259\/bjr.75.suppl_1.750025","article-title":"Response of Gaucher bone disease to enzyme replacement therapy","volume":"75","author":"Poll","year":"2002","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.bcmd.2010.09.001_bb0110","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1182\/blood-2005-12-5072","article-title":"Superior effects of high-dose enzyme replacement therapy in type 1 Gaucher disease on bone marrow involvement and chitotriosidase levels: a 2-center retrospective analysis","volume":"108","author":"de Fost","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2010.09.001_bb0115","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0002-9610(91)90363-I","article-title":"A 27-year experience with splenectomy for Gaucher's disease","volume":"161","author":"Fleshner","year":"1991","journal-title":"Am. J. Surg."},{"key":"10.1016\/j.bcmd.2010.09.001_bb0120","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0022-3476(95)70358-6","article-title":"Outcome of partial splenectomy for type I Gaucher disease","volume":"126","author":"Zimran","year":"1995","journal-title":"J. Pediatr."},{"key":"10.1016\/j.bcmd.2010.09.001_bb0125","first-page":"80","article-title":"Children with type I Gaucher disease: growing into adulthood with and without enzyme therapy","volume":"2","author":"Zimran","year":"2000","journal-title":"Isr. Med. Assoc. J."},{"key":"10.1016\/j.bcmd.2010.09.001_bb0130","doi-asserted-by":"crossref","first-page":"A2","DOI":"10.1259\/bjr.75.suppl_1.750002","article-title":"Skeletal aspects of Gaucher disease: a review","volume":"75","author":"Wenstrup","year":"2002","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.bcmd.2010.09.001_bb0135","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1359\/jbmr.061004","article-title":"Effect of enzyme replacement therapy with imiglucerase on BMD in type 1 Gaucher disease","volume":"22","author":"Wenstrup","year":"2007","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bcmd.2010.09.001_bb0140","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1399-0004.2008.00978.x","article-title":"Improvement of bone disease by imiglucerase (Cerezyme) therapy in patients with skeletal manifestations of type 1 Gaucher disease: results of a 48-month longitudinal cohort study","volume":"73","author":"Sims","year":"2008","journal-title":"Clin. Genet."},{"key":"10.1016\/j.bcmd.2010.09.001_bb0145","first-page":"267","article-title":"Skeletal manifestations in Gaucher disease: presentation and treatment","volume":"1","author":"Lebel","year":"1999","journal-title":"Isr. Med. Assoc. J."},{"key":"10.1016\/j.bcmd.2010.09.001_bb0150","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1054\/arth.2001.19162","article-title":"Outcome of total hip arthroplasty in patients with Gaucher disease","volume":"16","author":"Lebel","year":"2001","journal-title":"J. Arthroplasty"},{"key":"10.1016\/j.bcmd.2010.09.001_bb0155","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1017\/S026502150524228X","article-title":"Anaesthesia for total hip replacement in Gaucher's disease","volume":"23","author":"Ioscovich","year":"2006","journal-title":"Eur. J. Anaesthesiol."},{"key":"10.1016\/j.bcmd.2010.09.001_bb0160","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/00003086-198803000-00014","article-title":"Total hip arthroplasty in Gaucher's disease. Long-term prognosis","volume":"228","author":"Goldblatt","year":"1988","journal-title":"Clin. Orthop."},{"key":"10.1016\/j.bcmd.2010.09.001_bb0165","first-page":"531","article-title":"Aseptic osteomyelitis in Gaucher's disease","volume":"1","author":"Yossipovitch","year":"1965","journal-title":"Isr. J. Med. Sci."},{"key":"10.1016\/j.bcmd.2010.09.001_bb0170","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s002560100369","article-title":"Pseudo-osteomyelitic crisis upon presentation of Gaucher disease","volume":"30","author":"Weisstein","year":"2001","journal-title":"Skeletal Radiol."},{"key":"10.1016\/j.bcmd.2010.09.001_bb0175","first-page":"37","article-title":"Orthopaedic manifestations of Gaucher disease","volume":"65","author":"Lutsky","year":"2007","journal-title":"Bull. N.Y.U. Hosp. Jt. Dis."},{"key":"10.1016\/j.bcmd.2010.09.001_bb0180","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3748\/wjg.14.176","article-title":"Overwhelming postsplenectomy infection syndrome in adults\u2014a clinically preventable disease","volume":"14","author":"Okabayashi","year":"2008","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bcmd.2010.09.001_bb0185","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1365-2141.1993.tb08270.x","article-title":"Abnormal neutrophil chemotaxis in Gaucher disease","volume":"83","author":"Aker","year":"1993","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2010.09.001_bb0190","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10545-008-0779-z","article-title":"Management of non-neuronopathic Gaucher disease with special reference to pregnancy, splenectomy, bisphosphonate therapy, use of biomarkers and bone disease monitoring","volume":"31","author":"Cox","year":"2008","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bcmd.2010.09.001_bb0195","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/ajh.21362","article-title":"The underrecognized progressive nature of N370S Gaucher disease and assessment of cancer risk in 403 patients","volume":"84","author":"Taddei","year":"2009","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2010.09.001_bb0200","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/ajh.21369","article-title":"Enzyme replacement therapy for mild patients with Gaucher disease","volume":"84","author":"Zimran","year":"2009","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2010.09.001_bb0205","first-page":"167","article-title":"Surgical treatment of osteonecrosis of the hip","volume":"55","author":"Mont","year":"2006","journal-title":"Instr. Course Lect."},{"key":"10.1016\/j.bcmd.2010.09.001_bb0210","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3109\/17453670902930032","article-title":"Poor results of drilling in early stages of juxta-articular osteonecrosis in 12 joints affected by Gaucher disease","volume":"80","author":"Lebel","year":"2009","journal-title":"Acta Orthop."},{"key":"10.1016\/j.bcmd.2010.09.001_bb0215","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/(SICI)1096-8652(199906)61:2<103::AID-AJH5>3.0.CO;2-V","article-title":"Platelet function abnormalities in Gaucher disease patients","volume":"61","author":"Gillis","year":"1999","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2010.09.001_bb0220","first-page":"673","article-title":"Iliopsoas hematoma in a young patient with type I Gaucher disease","volume":"5","author":"Jmoudiak","year":"2003","journal-title":"Isr. Med. Assoc. J."},{"key":"10.1016\/j.bcmd.2010.09.001_bb0225","doi-asserted-by":"crossref","first-page":"591","DOI":"10.2106\/00004623-198163040-00009","article-title":"Hip arthroplasties in Gaucher's disease","volume":"63","author":"Lau","year":"1981","journal-title":"J. Bone Joint Surg. Am."},{"key":"10.1016\/j.bcmd.2010.09.001_bb0230","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF00443393","article-title":"Gaucher disease\u2014the orthopaedic aspect. Report of seven cases","volume":"114","author":"Tauber","year":"1995","journal-title":"Arch. Orthop. Trauma Surg."},{"key":"10.1016\/j.bcmd.2010.09.001_bb0235","first-page":"1099","article-title":"Long-term follow-up of a total articular resurfacing arthroplasty and a cup arthroplasty in Gaucher's disease","volume":"21","author":"Sellman","year":"1992","journal-title":"Orthop. Rev."},{"key":"10.1016\/j.bcmd.2010.09.001_bb0240","first-page":"130","article-title":"Cementless total hip arthroplasties in Gaucher disease: long-term follow-up","volume":"38","author":"Lebel","year":"2009","journal-title":"Am. J. Orthop."},{"key":"10.1016\/j.bcmd.2010.09.001_bb0245","first-page":"579","article-title":"Long-term results of the ABG-1 hydroxyapatite coated total hip arthroplasty: analysis of 111 cases with a minimum follow-up of 10years","volume":"95","author":"Bidar","year":"2009","journal-title":"Rev. Chir. Orthop. Traumatol."},{"key":"10.1016\/j.bcmd.2010.09.001_bb0250","article-title":"Wear comparison between a highly cross-linked polyethylene and conventional polyethylene against a zirconia femoral head minimum 5-year follow-up","author":"Fukui","year":"2010","journal-title":"J. Arthroplasty"},{"key":"10.1016\/j.bcmd.2010.09.001_bb0255","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1302\/0301-620X.89B3.18520","article-title":"Transplacental transfer of cobalt and chromium in patients with metal-on-metal hip arthroplasty: a controlled study","volume":"89","author":"Ziaee","year":"2007","journal-title":"J. Bone Joint Surg. Br."},{"key":"10.1016\/j.bcmd.2010.09.001_bb0260","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1302\/0301-620X.91B12.22515","article-title":"Total hip replacement in Gaucher's disease: effects of enzyme replacement therapy","volume":"91","author":"Bubbar","year":"2009","journal-title":"J. Bone Joint Surg. Br."},{"key":"10.1016\/j.bcmd.2010.09.001_bb0265","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.bcmd.2009.08.002","article-title":"The clinical course of untreated Gaucher disease in 22 patients over 10years: hematological and skeletal manifestations","volume":"43","author":"Piran","year":"2009","journal-title":"Blood Cells Mol. Dis."}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979610002123?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979610002123?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:27:54Z","timestamp":1761049674000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979610002123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S1079979610002123"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2010.09.001","relation":{},"ISSN":["1079-9796"],"issn-type":[{"type":"print","value":"1079-9796"}],"subject":[],"published":{"date-parts":[[2011,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hip arthroplasty in patients with Gaucher disease","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2010.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}